This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Fudan University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Inventor Fazhi Yu: Pioneering Innovations in Pharmaceutical Chemistry
Introduction
Fazhi Yu is an accomplished inventor based in Shanghai, China, with a focus on developing innovative pharmaceutical compounds. With a notable track record of securing patents, he is particularly recognized for his contributions to the field of biaryl urea derivatives, which play a crucial role in medical treatments.
Latest Patents
Fazhi Yu holds two patents, both of which are centered around a biaryl urea RORγt inhibitor. His recent work details the invention of a biaryl urea derivative or salt thereof, comprising a specific formula that exhibits RORγt inhibiting activity. This innovation not only outlines the preparation process for such compounds but also discusses the potential applications of these derivatives in treating RORγt-related diseases. This advancement could significantly impact therapeutic strategies in the pharmaceutical landscape.
Career Highlights
Fazhi Yu is currently associated with Fudan University, where he engages in cutting-edge research that bridges the gap between chemistry and medicine. His profound understanding of pharmaceutical formulations and their mechanisms positions him as a leading figure in his field, making substantial contributions to academic and practical advancements alike.
Collaborations
Throughout his career, Fazhi has collaborated closely with notable colleagues including YongHui Wang and Yafei Huang. These partnerships have fostered a dynamic research environment, enabling the exploration of innovative solutions in pharmaceutical chemistry and enhancing the collective impact of their work.
Conclusion
Fazhi Yu's contributions to innovation, particularly in the realm of biaryl urea derivatives, underscore his role as a significant inventor in the pharmaceutical field. With his ongoing research at Fudan University, he continues to pave the way for new therapeutic options, potentially transforming the way RORγt-related conditions are treated and managed. His commitment to scientific advancement stands as a testament to his dedication to improving health outcomes through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
